Home Page News Opinion Foreign Policy Politics Policy Legislation Lobbying Hill Life & People Hill Climbers Heard On The Hill Calendar Archives Classifieds
Hill Times Events Inside Ottawa Directory Hill Times Store Hill Times Careers The Wire Report The Lobby Monitor Parliament Now
Subscribe Free Trial Reuse & Permissions Advertising
Log In
Policy Briefing: Biotechnology
Foreign Minister Chrystia Freeland speaks to reporters in Ottawa in August about NAFTA renegotiations, the third round of which is set to take place Sept. 23 to 27 in Canada's capital. The Hill Times photograph by Sam Garcia

How reworking NAFTA will affect intellectual property in Canada

Expect another tussle over whether to extend data exclusivity from eight years to 12.
But not everyone is happy with the SR&ED program. Critics say it’s ineffective and complicated.
It’s best to put money in the game, but let the experts in the private sector decide on where to spend it, say industry reps.
The Liberals have launched funds to support high-tech businesses and promised to review intellectual property rules.
Science is a long game. Funding for research and scholarships now will pay off in future.
Insurance companies already discriminate based on lifestyle choices and family history, so why not genetics? A genome is not under your control, unlike a smoking habit or skydiving hobby.
Canadian innovators' apparent preference for filing patents in the United States over Canada shows a disconnect between labs and the marketplace in this country.
On the one hand, access is the first ingredient in innovation. On the other, letting technology flow freely could lead to misuse and regulatory trouble.

Your group subscription includes premium access to Politics This Morning briefing.